Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | HPGD | P15428 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PTPRC | P08575 | 1/20 | 0.35 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14067104 | 0.84 | ITGB2 (0.38) | ALDH1A1KMT2A | |
| SCHEMBL102784 | 0.84 | ITGB2 (0.38) | ALDH1A1KMT2A | |
| Hydrogen Sulfide SCHEMBL28295724 | 0.82 | ITGB2 (0.36) | ALDH1A1KMT2A | |
| Potassium SCHEMBL30808411 | 0.82 | ITGB2 (0.36) | ALDH1A1KMT2A | |
| Lithium SCHEMBL30114456 | 0.82 | ITGB2 (0.36) | ALDH1A1KMT2A | |
| SCHEMBL71084 | 0.80 | ABCG2 (0.43) | PTGS2PKMTSHRABCG2ALDH1A1 | |
| SCHEMBL212973 | 0.80 | KMT2A (0.34) | ALDH1A1KMT2A | |
| SCHEMBL209608 | 0.80 | CA1 (0.37) | ALDH1A1KMT2A | |
| SCHEMBL1758350 | 0.80 | GSTP1 (0.45) | PTGS2PKMTSHRABCG2ALDH1A1 | |
| SCHEMBL2232672 | 0.80 | KMT2A (0.36) | PTGS2ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 265 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0105825-B1 | MULTI-LAYER POLYISOPHTHALATE AND POLYTEREPHTHALATE ARTICLES AND PROCESS THEREFOR | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1987-11-04 | — | — | EP | claimed |
| US-20260138947-A1 | BENZYLTRYPTAMINE COMPOUNDS | REUNION NEUROSCIENCE INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260070309-A1 | POLYHYDROXYALKANOATE-BASED PACKAGING FILMS AND ARTICLES MADE THEREWITH | NEWLIGHT TECHNOLOGIES, INC. (US) | 2026-03-12 | — | — | US | disclosed |
| US-20260042735-A1 | BENZYLTRYPTAMINE COMPOUNDS | REUNION NEUROSCIENCE INC (US) | 2026-02-12 | — | — | US | disclosed |
| EP-4628539-A1 | COMPOSITION FOR BIODEGRADABLE FILM, BIODEGRADABLE FILM COMPRISING SAME, AND METHOD FOR MANUFACTURING BIODEGRADABLE FILM | CJ CheilJedang Corporation (KR) | 2025-10-08 | — | — | EP | disclosed |
| US-20250257041-A1 | INDUCERS OF INTEGRATED STRESS RESPONSE TO TREAT CANCER | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2025-08-14 | — | — | US | disclosed |
| EP-4567175-A1 | COMPOSITION FOR BIODEGRADABLE MELTBLOWN NONWOVEN FABRIC, AND BIODEGRADABLE MELTBLOWN NONWOVEN FABRIC MANUFACTURED USING SAME | CJ CheilJedang Corporation (KR) | 2025-06-11 | — | — | EP | disclosed |
| EP-4541853-A1 | BIODEGRADABLE RESIN COMPOSITION, BIODEGRADABLE NONWOVEN FABRIC, AND METHOD FOR PRODUCING SAME | CJ CheilJedang Corporation (KR) | 2025-04-23 | — | — | EP | disclosed |
| EP-4526291-A1 | INDUCERS OF INTEGRATED STRESS RESPONSE TO TREAT CANCER | The Board of Regents of the University of Texas System (US) | 2025-03-26 | — | — | EP | disclosed |
| US-20250092251-A1 | MULTIPHASED POLYHYDROXYALKANOATE-BASED COMPOSITIONS AND ARTICLES MADE THEREFROM | NEWLIGHT TECHNOLOGIES, INC. | 2025-03-20 | — | — | US | disclosed |
| CN-1325385-A | Gastrin and cholecystokinin receptor ligands | BLACK JAMES FOUNDATION (GB) | 2001-12-05 | — | — | CN | disclosed |
| US-6232338-B1 | 4-Mercaptopyrrolidine derivatives as farnesyl transferase inhibitors | ZENECA LIMITED (GB) | 2001-05-15 | — | — | US | disclosed |
| EP-1097967-A2 | Biodegradable resin composition and its molded product | Nippon Shokubai Co., Ltd. (JP) | 2001-05-09 | — | — | EP | disclosed |
| US-6187285-B1 | IN PARTICULAR MAGNETIC RESONANCE IMAGING (MRI) FOR MAGNETIC CATIONS. | GUERBET (FR) | 2001-02-13 | — | — | US | disclosed |
| WO-2000075224-A1 | BLENDS OF POLYESTER COPOLYMER AND ETHYLENE VINYL ACETATE WITH IMPROVED GAS BARRIER PROPERTIES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-12-14 | — | — | WO | disclosed |
| EP-0842151-A1 | 4-MERCAPTOPYRROLIDINE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS | ZENECA LIMITED (GB) | 1998-05-20 | — | — | EP | disclosed |
| WO-1997006138-A1 | 4-MERCAPTOPYRROLIDINE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS | ZENECA LIMITED (GB) | 1997-02-20 | — | — | WO | disclosed |
| US-5434239-A | Esterification, condensation polymerization | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1995-07-18 | — | — | US | disclosed |
| CN-1051178-A | New heterogeneous ring compound and preparation method thereof | YAMANOUCHI PHARMA CO LTD (JP) | 1991-05-08 | — | — | CN | disclosed |
| US-4024173-A | Process for the manufacture of cyclohexene dicarboxylic acid esters | DYNAMIT NOBEL AKTIENGESELLSCHAFT (DT) | 1977-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250257041-A1 | INDUCERS OF INTEGRATED STRESS RESPONSE TO TREAT CANCER | DDIT3, ATF4, EIF2AK3 | PTGS2 1399/4885PKM 2829/4885TSHR 4131/4885 |
| US-20260070309-A1 | POLYHYDROXYALKANOATE-BASED PACKAGING FILMS AND ARTICLES MADE THEREWITH | PHB2, PWWP2B, PHB1 | PTGS2 2306/4885PKM 415/4885TSHR 3636/4885 |
| US-20260042735-A1 | BENZYLTRYPTAMINE COMPOUNDS | HTR2C, HTR2A, HTR6 | PTGS2 359/4885PKM 2073/4885TSHR 490/4885 |
| US-20260138947-A1 | BENZYLTRYPTAMINE COMPOUNDS | HTR2C, CNR2, HTR3B | PTGS2 246/4885PKM 2834/4885TSHR 347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.